Skip to search formSkip to main contentSkip to account menu

falintolol

Known as: O-(3-(tert-butylamino)-2-hydroxypropyl)cyclopropyl methyl ketone oxime 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Propanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Synthesis of new delta 2-isoxazoline derivatives and their pharmacological characterization as beta-adrenergic receptor antagonists.
A series of delta 2-isoxazoline derivatives structurally related to Broxaterol 1 and Falintolol 3 has been prepared and evaluated… 
1989
1989
Pharmacokinetics of falintolol II. Absorption, distribution and elimination from tissues and organs following ocular administration and intravenous injection of falintolol in albino rabbits.
The absorption, distribution and elimination of falintolol maleate was studied in various ocular and extraocular tissues and… 
1987
1987
Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
Changes in intraocular pressure (IOP) following topical administration of falintolol (0.5%-0.25%), a new beta-blocking agent… 
1987
1987
Determination of falintolol, a new aliphatic beta-adrenergic antagonist, in whole blood by gas chromatography with electron-capture detection: geometric isomers resolution.
Falintolol oxalate, a new beta-adrenergic antagonist, is characterized by the presence of an oxime function and exists in a… 
1985
1985
New chiral and isomeric cyclopropyl ketoxime propanolamine derivatives with potent beta-adrenergic blocking properties.
The synthesis of R-(+) and S-(-) isomers of O-[3-tert-butylamino)-2-hydroxypropyl] cyclopropyl methyl ketone oxime (falintolol… 
1985
1985
In vitro potential measurement, anaesthetic and antimicrobial effects as indicators of beta-blocker toxicity of the cornea.
Three tests were utilized to determine and compare the toxicity of timolol, propranolol and two new aliphatic and alicyclic oxime… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License